Skip to main content
Premium Trial:

Request an Annual Quote

Michael Forrest Named to AlphaGene's Board

Premium

WOBURN, Mass.--Michael Forrest, president and CEO of the drug discovery company Cellegy Pharmaceuticals, has been ap pointed to the board of directors of AlphaGene Inc., a bioinformatics and medical genomics company here.

Forrest previously served as president and CEO of Mercator Genetics, a genomics company focused on positional cloning, and of Transkaryotic Therapies Inc. He has also worked for American Cyanamid and Pfizer.

Filed under

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.